Boston Scientific Corporation BSX
43.92
(0.76)
(1.70%)
as of 25 Sep
- Market cap
- $64.7B
- P/E
- 17.7×
Follow BSX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Boston Scientific Corporation (BSX) EV/Sales
As of 25 September 2026, Boston Scientific Corporation (BSX) trades at a EV/Sales of 3.7×. Over the past ten years it has ranged from 2.9× (January 2015) to 9.9× (February 2025); the current reading is higher than 3% of that period. That is above the Medical Devices industry median of 2.4× and in line with the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 7.5× | (11.36%) |
| FY2024 | 8.5× | 30.63% |
| FY2023 | 6.5× | 11.32% |
| FY2022 | 5.8× | 2.43% |
| FY2021 | 5.7× | (3.43%) |
| FY2020 | 5.9× | (13.12%) |
| FY2019 | 6.8× | 19.43% |
| FY2018 | 5.7× | 28.09% |
| FY2017 | 4.4× | 6.12% |
| FY2016 | 4.2× | 3.69% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.6× | (28.49%) |
| Mar 2026 | 5.0× | (33.57%) |
| Dec 2025 | 7.5× | (6.31%) |
| Sep 2025 | 8.0× | (12.87%) |
| 42 more quarters | Free account |
Against its own ten years
Low 2.9×
High 9.9×
Ten-year median
5.8×
Current reading's percentile
3
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.9× |
| MDT Medtronic PLC compare | 3.5× |
| STE STERIS plc compare | 3.6× |
| BSX Boston Scientific Corporation | 3.7× |
| ABT Abbott Laboratories compare | 4.4× |
| SYK Stryker Corporation compare | 4.5× |
| DXCM DexCom, Inc. compare | 6.5× |
| EW Edwards Lifesciences Corporation compare | 7.1× |
| Medical Devices industry median | 2.4× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on BSX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement